Literature DB >> 27876591

Cystic Fibrosis and the Nervous System.

Leah R Reznikov1.   

Abstract

Cystic fibrosis (CF) is a life-shortening autosomal recessive disorder caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). CFTR is an anion channel that conducts bicarbonate and chloride across cell membranes. Although defective anion transport across epithelial cells is accepted as the basic defect in CF, many of the features observed in people with CF and organs affected by CF are modulated by the nervous system. This is of interest because CFTR expression has been reported in both the peripheral and central nervous systems, and it is well known that the transport of anions, such as chloride, greatly modulates neuronal excitability. Thus it is predicted that in CF, lack of CFTR in the nervous system affects neuronal function. Consistent with this prediction, several nervous system abnormalities and nervous system disorders have been described in people with CF and in animal models of CF. The goal of this special feature article is to highlight the expression and function of CFTR in the nervous system. Special emphasis is placed on nervous system abnormalities described in people with CF and in animal models of CF. Finally, features of CF that may be modulated by or attributed to faulty nervous system function are discussed.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CFTR; cough; cystic fibrosis; glucose regulation; mucus secretion; nervous system

Mesh:

Substances:

Year:  2016        PMID: 27876591      PMCID: PMC5472519          DOI: 10.1016/j.chest.2016.11.009

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  115 in total

1.  Decreased adenosine 3':5'-monophosphate response to isoproterenol in cystic fibrosis leukocytes.

Authors:  P B Davis; M Braunstein; C Jay
Journal:  Pediatr Res       Date:  1978-06       Impact factor: 3.756

Review 2.  Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease.

Authors:  A S Verkman; Yuanlin Song; Jay R Thiagarajah
Journal:  Am J Physiol Cell Physiol       Date:  2003-01       Impact factor: 4.249

3.  Autonomic nervous system abnormalities in cystic fibrosis.

Authors:  P B Davis; M Kaliner
Journal:  J Chronic Dis       Date:  1983

4.  CFTR expression in cortical collecting duct cells.

Authors:  K M Todd-Turla; E Rusvai; A Náray-Fejes-Tóth; G Fejes-Tóth
Journal:  Am J Physiol       Date:  1996-01

Review 5.  Parasympathetic control of airway submucosal glands: central reflexes and the airway intrinsic nervous system.

Authors:  Jeffrey J Wine
Journal:  Auton Neurosci       Date:  2007-03-09       Impact factor: 3.145

Review 6.  Modifying disease in cystic fibrosis: current and future therapies on the horizon.

Authors:  Thida Ong; Bonnie W Ramsey
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

7.  Processing and function of CFTR-DeltaF508 are species-dependent.

Authors:  Lynda S Ostedgaard; Christopher S Rogers; Qian Dong; Christoph O Randak; Daniel W Vermeer; Tatiana Rokhlina; Philip H Karp; Michael J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-14       Impact factor: 11.205

8.  Identification of the cystic fibrosis gene: chromosome walking and jumping.

Authors:  J M Rommens; M C Iannuzzi; B Kerem; M L Drumm; G Melmer; M Dean; R Rozmahel; J L Cole; D Kennedy; N Hidaka
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

9.  Glial cells express multiple ATP binding cassette proteins which are involved in ATP release.

Authors:  Patrizia Ballerini; Patrizia Di Iorio; Renata Ciccarelli; Eleonora Nargi; Iolanda D'Alimonte; Ugo Traversa; Michel P Rathbone; Francesco Caciagli
Journal:  Neuroreport       Date:  2002-10-07       Impact factor: 1.837

10.  Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass.

Authors:  Aliye Uc; Alicia K Olivier; Michelle A Griffin; David K Meyerholz; Jianrong Yao; Maisam Abu-El-Haija; Katherine M Buchanan; Oriana G Vanegas Calderón; Marwa Abu-El-Haija; Alejandro A Pezzulo; Leah R Reznikov; Mark J Hoegger; Michael V Rector; Lynda S Ostedgaard; Peter J Taft; Nick D Gansemer; Paula S Ludwig; Emma E Hornick; David A Stoltz; Katie L Ode; Michael J Welsh; John F Engelhardt; Andrew W Norris
Journal:  Clin Sci (Lond)       Date:  2015-01       Impact factor: 6.124

View more
  14 in total

Review 1.  Sleep disturbances and their impact in pediatric cystic fibrosis.

Authors:  Aarti Shakkottai; Louise M O'Brien; Samya Z Nasr; Ronald D Chervin
Journal:  Sleep Med Rev       Date:  2018-07-06       Impact factor: 11.609

2.  Sleep Phase Delay in Cystic Fibrosis: A Potential New Manifestation of Cystic Fibrosis Transmembrane Regulator Dysfunction.

Authors:  Judy L Jensen; Christopher R Jones; Christiana Kartsonaki; Kristyn A Packer; Frederick R Adler; Theodore G Liou
Journal:  Chest       Date:  2017-04-23       Impact factor: 9.410

Review 3.  The Clinical Biology of Cystic Fibrosis Transmembrane Regulator Protein: Its Role and Function in Extrapulmonary Disease.

Authors:  Theodore G Liou
Journal:  Chest       Date:  2018-10-22       Impact factor: 9.410

4.  Long-term culturing of porcine nodose ganglia.

Authors:  Shin-Ping Kuan; Kalina R Atanasova; Maria V Guevara; Emily N Collins; Leah R Reznikov
Journal:  J Neurosci Methods       Date:  2019-12-09       Impact factor: 2.390

5.  Simple and reproducible approaches for the collection of select porcine ganglia.

Authors:  David K Meyerholz; Leah R Reznikov
Journal:  J Neurosci Methods       Date:  2017-06-08       Impact factor: 2.390

6.  Sympatho-Vagal Dysfunction in Patients with End-Stage Lung Disease Awaiting Lung Transplantation.

Authors:  Eleonora Tobaldini; Gabriel D Rodrigues; Giorgio Mantoan; Alice Monti; Giulia Coti Zelati; Camilla Cirelli; Paolo Tarsia; Letizia Corinna Morlacchi; Valeria Rossetti; Ilaria Righi; Mario Nosotti; Pedro Paulo da S Soares; Nicola Montano; Stefano Aliberti; Francesco Blasi
Journal:  J Clin Med       Date:  2020-04-17       Impact factor: 4.241

7.  CNS imaging studies in cystic fibrosis patients presenting with sudden neurological events.

Authors:  Samantha Ellis; Catherine Rang; Tom Kotsimbos; Dominic Keating; Felicity Finlayson; Richard Stark; Dominic Thyagarajan; John Wilson
Journal:  BMJ Open Respir Res       Date:  2019-08-09

Review 8.  Chloride - The Underrated Ion in Nociceptors.

Authors:  Bettina U Wilke; Kai K Kummer; Michael G Leitner; Michaela Kress
Journal:  Front Neurosci       Date:  2020-04-08       Impact factor: 4.677

Review 9.  Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis.

Authors:  Kalina R Atanasova; Leah R Reznikov
Journal:  Respir Res       Date:  2018-08-06

Review 10.  The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis.

Authors:  Valentine Sergeev; Frank Y Chou; Grace Y Lam; Christopher Michael Hamilton; Pearce G Wilcox; Bradley S Quon
Journal:  Ann Am Thorac Soc       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.